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Abstract
Introduction. Heavy and chronic alcohol use con-
notes frequent, continuous and persistent consump-
tion of alcoholic drinks over an extended period of 
time. Importantly, heavy consumption of alcohol 
causes many health problems to the drinker and the 
society at large, as over 5.1% of the global burden 
of morbidity and injuries are attributable to alcohol 
usage alone.
Aim. The purpose of this study is to identify some of 
the noncommunicable diseases that are associated 
with chronic alcohol consumption through a system-
atic and narrative review, with detailed descriptions 
of the occurrences. 
Methods. A systematic and narrative review of lit-
erature that evaluates noncommunicable diseases 
associated with chronic alcohol consumption was 
carried out using Google, Medline and databases of 
major international health organizations. Keywords 
used as search terms were alcoholism, chronic al-
cohol use and heavy alcohol use; these terms were 
matched with occurrences and risk of noncommuni-
cable diseases. Studies included in this review are 
clinical trials, meta-analyses, randomized controlled 
trials, and systematic and review articles.
Results. The findings revealed that chronic alcohol 
use is either a single or joint risk factor for Alzhei-
mer’s disease and dementia, arthritis, brain malfunc-
tion, cancer (most commonly of the oropharynx, 
larynx, oesophagus, liver, colon, rectum or breast), 
chronic obstructive pulmonary disease (COPD), dia-
betes, epilepsy, heart diseases and cardiovascular 
diseases, immune system dysfunction, malnourish-
ment and vitamin deficiencies, mood disorders, bipo-
lar disorder and depression, osteoporosis and bone 
malformation, pancreatitis, and ulcers and gastroin-
testinal problems.
Conclusion. These findings are background informa-
tion as they revealed some of the noncommunicable 
diseases associated with chronic alcohol use. Hence, 
more and precise long-term cohort studies are neces-
sary for a better understanding of the occurrences 
and epidemiology of noncommunicable diseases as a 
result of chronic alcohol use. 
Chronic Alcohol Use and Accompanying 
Noncommunicable Diseases
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consumption causes death and disability relatively 
early in life (1). In addition, in the age range of 20-
39, approximately 13.5% of total deaths are linked 
to alcohol (1). In Britain, there were over eight thou-
sand deaths linked to alcohol abuse in 2007 (13.3 
per 100.000 population in 2007). Although this was 
lower than in 2006, it was double the number of re-
corded deaths in 1991 (6.9 per 100.000 population 
in 1991) (4). Also, the findings from a study from the 
United Kingdom revealed that alcohol consumption 
causes about 4.1% of cancer cases in the UK (12.500 
cases per year) (5). In Scotland, the National Health 
Scheme (NHS) estimated that in 2003 one in every 
twenty deaths could be linked to alcohol abuse (6). 
Furthermore, in Scotland, a 2009 report noted that 
the death rate from alcohol-related diseases was 
9,000, a number three times that of 25 years previ-
ously (7).
In Russia, excessive alcohol consumption, especially 
among men, has recently caused more than half of 
all the deaths between the ages of 15 and 54 (8). In 
the United States of America, heavy alcohol use is 
the fourth leading preventable cause of death, as it 
results in approximately 88.000 deaths yearly, which 
includes one in ten overall deaths among adults be-
tween the ages of 20 and 64 (3,9). Furthermore, 
heavy alcohol use alone costs the US government 
over 249 billion dollars, approximately $2.05 per 
drink in 2010 (9). 
Chronic alcohol use incorporates binge drinking, 
heavy drinking and any form of alcohol consumption 
by pregnant women or anyone under 21 years of age 
(9). Binge drinking is characterized as the intake of 
more than three alcoholic drinks on one occasion for 
a woman, or the intake of more than four consecu-
tive alcoholic drinks for a man, while heavy drinking 
is characterized as the intake of more than seven al-
coholic drinks in a week for a woman, or more than 
fourteen alcoholic drinks in a week for a man (9). 
According to the Centers for Disease Control and 
Prevention (CDC), more than half of all deaths and 
three-quarters of the costs due to excessive alcohol 
consumption are the result of binge drinking (9). It 
has been further estimated that over 36.5 million of 
US adults, approximately one in six, binge drink at 
least once per week, with an average consumption of 
more than six alcoholic drinks per binge, resulting in 
an overall consumption of 17 billion binge drinks an-
nually by US adults, approximately 470 binge drinks 
per an individual binge drinker (9).
Introduction 
Heavy or chronic alcohol use connotes frequent, 
continuous and persistent consumption of alcoholic 
drinks over an extended period of time which is de-
structive and deleterious to health because it nega-
tively affects the body overall. Alcohol, also known 
as liquor or ethanol, is a psychoactive substance with 
a high dependency rate, and has been used in nu-
merous societies and cultures for decades (1). Heavy 
consumption of alcohol causes many problems to the 
drinker and the society at large, posing a risk factor 
for various diseases and infections, as well as caus-
ing social and economic burden and harm to other 
people, for example families, relatives, friends, work 
associates and strangers (1). 
Alcohol abuse can have severe consequences for 
the abuser (2). When large amounts of alcohol are 
consumed, the excess builds up in the bloodstream. 
Afterwards, the heart circulates alcohol throughout 
the body, leading to alterations in the normal bod-
ily functions, and a single bout of binge-drinking can 
result in significant bodily impairment, damage, or 
even death (3). If excessive alcohol consumption oc-
curs consistently, it can lead to the development of 
many chronic diseases and other serious health prob-
lems (3). Statistics suggest that alcohol abuse results 
in over three million deaths worldwide every year, 
which represents 5.4% of all global deaths (1). Fur-
thermore, alcohol abuse is a risk factor for over two 
hundred diseases and types of injuries (1). Likewise, 
heavy consumption of alcohol is associated with the 
risk of developing mental and behavioural disorders, 
alcohol dependence, major noncommunicable diseas-
es such as liver cirrhosis, some types of cancer and 
cardiovascular diseases, as well as injuries resulting 
from violence and traffic accidents (1). Importantly, 
the consequences for health associated with heavy 
alcohol intake are enormous, and the focus of this 
study is on the accompanying noncommunicable dis-
eases that are associated with heavy and chronic al-
cohol consumption.
The pattern of alcohol use in the world 
According to the World Health Organization (WHO), 
over 5.1% of the global burden of morbidity and 
injury is attributable to alcohol usage, as alcohol 
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Chronic alcohol use and 
noncommunicable diseases
Excessive consumption of alcohol over a long period 
of time predisposes an individual to organ and sys-
tem damage (10). Likewise, extended heavy alcohol 
use predisposes an individual to the onset of chronic 
diseases and other serious problems, for instance al-
cohol use disorder (AUD) and problems with learning, 
memory and mental health (9,11-14).
Results and discussion
Alzheimer’s disease and dementia: There is an un-
derlying neurobiological link between alcohol use and 
Alzheimer’s disease (AD) (3). This is confirmed by the 
fact that alcohol use, alcohol abuse and dependence 
cause cognitive impairment (15). Also, alcohol adds 
to the cognitive burden seen in dementia through ad-
ditional mechanisms of neurodegenerative process-
es and may contribute at various mechanistic points 
in the genesis and sustenance of AD pathology via 
neuroinflammation (15). 
Heavy alcohol consumption is associated with a 
faster rate of cognitive decline in AD patients, sug-
gesting that it may accelerate the progression of 
AD (16). Therefore, drinking habits might alter the 
course of AD negatively (16). In addition, there is am-
ple evidence of a causal association between alcohol 
consumption and an earlier Alzheimer’s disease age 
of onset survival (AAOS) and increased γ-glutamyl 
transferase blood concentrations (17). Although 
modest alcohol consumption (≤12.5 g/day) is associ-
ated with a reduced risk of dementia, with 6 g/day 
of alcohol conferring a lower risk than other levels, 
excessive drinking (≥38 g/day) may instead elevate 
the risk (18). 
Finally, long-term consumption of alcohol aggravates 
cognitive decline, increases the permeability of the 
blood-brain barrier (BBB), leads to pathomorphologi-
cal changes and downregulates some related struc-
tural proteins (zonula occludens-1, VE-cadherin, and 
occludin) and functional proteins (major facilitator 
super family domain-containing protein-2a [Mfs-
d2a]), low- density lipoprotein receptor-related pro-
Methods
A combination of the systematic and the narrative 
review approach was adopted for this study. A sys-
tematic review was used to identify and select viable 
studies, while a narrative review was used to provide 
detailed explanations and descriptions of the studies 
identified. The keywords used as search terms were 
alcoholism, chronic alcohol use and heavy alcohol 
use, and these terms were then matched with the 
occurrences of noncommunicable diseases.
Inclusion and exclusion criteria
Google and Medline databases were searched ex-
tensively, and the studies included in this review are 
clinical trials, meta-analyses, randomized controlled 
trials and systematic and review articles. Further-
more, the databases of major national and interna-
tional health organizations (for example, The World 
Health Organization and Centers for Disease Control 
and Prevention) were searched to obtain relevant 
data for the study. 
The researchers also included the full text of articles 
written in English, while abstracts written in other 
languages were translated into English. The year of 
publication was not a criterion in the selection of 
studies. Afterwards, extensive data screening was 
performed, and all documents that do not concur with 
the aims and objectives of the study were excluded 
in the final analysis to reduce the number of studies.
Papers included in the final analysis
Upon the entry of the keywords into the databases, 
thousands of potential articles were obtained. Af-
ter analysing the titles of the papers, the second 
step was the analysis of their abstracts. Extensive 
screening was performed, and the inclusion and ex-
clusion criteria were fully implemented, reducing the 
number of studies to appropriate numbers. 80 stud-
ies were included from the Medline database, while 
9 other documents were obtained from other data-
bases. In total, eighty-nine (89) studies were deemed 
appropriate and were included in this review study 
for detailed narration. 
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findings of this study showed the association be-
tween alcohol consumption and spinal structural pro-
gression in axial spondyloarthritis (axSpA) patients 
for the first time (20). Also, increased body mass 
index (BMI) and even moderate alcohol intake were 
associated with an increased risk of psoriatic arthritis 
(PsA) in people with psoriasis (21). 
Some studies have shown that moderate alcohol 
consumption offers protection against rheumatoid 
arthritis (RA). For instance, according to a study on 
the interplay between alcohol, smoking and human 
leucocyte antigen (HLA) genes in RA aetiology, the 
findings revealed that, when compared with non-
drinking, low and moderate alcohol consumption was 
tein-1 (LRP1), receptor for advanced glycation end 
products (RAGE), and aquaporin-4 (AQP4) in the BBB 
(19). Hence, these novel findings suggest that long-
term consumption of alcohol induces neural lesions, 
which is related to the destruction of the integrity of 
the blood-brain barrier (BBB) (19). 
Arthritis: Chronic alcohol consumption is also linked 
to arthritis (3). A study on alcohol consumption as a 
predictor of the progression of spinal structural dam-
age in axial spondyloarthritis revealed that drinking 
alcohol showed a significant correlation with the 
progression of spinal structural damage for both 
modified Stoke Ankylosing Spondylitis Spinal Score 
(mSASSS) and syndesmophyte progression (20). The 
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velopmental period, which could result in neural reor-
ganization and increased risk for developing alcohol 
use disorder in the future (27). 
Cancer: Chronic alcohol consumption increases the 
chances of developing different types of cancer, in-
cluding cancer of the mouth, oesophagus, larynx, 
stomach, liver, colon and rectum, as well as breast 
malignancies, since both acetaldehyde and alcohol 
itself contribute to this heightened risk (3). 
There is strong evidence that alcohol causes cancer 
in seven places in the body, and probably others as 
well. These are the cancer of the oropharynx, larynx, 
oesophagus, liver, colon, rectum and breast, and cur-
rent estimates suggest that alcohol-attributable can-
cers at these sites make up 5.8% of all cancer deaths 
globally (28,29). Also, there is some evidence of re-
versibility of risk in laryngeal, pharyngeal and liver 
cancers when alcohol consumption ceases (28,29). 
All types of alcoholic beverages are associated with 
an increased risk of cancer, which suggests that eth-
anol itself is the crucial compound that causes this 
effect (30). 
The International Agency for Research for Cancer 
has classified alcohol consumption and acetaldehyde 
associated with alcohol consumption as carcinogenic 
for humans (group 1): the oral cavity, pharynx, lar-
ynx, oesophagus, colon, rectum, liver and female 
breast are places where cancer develops as a result 
of alcohol consumption (30). Although the process 
by which alcohol consumption exerts its carcinogenic 
effects has not been fully understood, credible occur-
rences include: a genotoxic effect of acetaldehyde; 
increased oestrogen concentration, which is impor-
tant for breast carcinogenesis; a role as solvent of 
tobacco carcinogens; production of reactive oxygen 
species and nitrogen species; and change in folate 
metabolism (30). Furthermore, there is a linear in-
crease in diseases as the intake of alcohol increases: 
oral, oesophagus, and colon cancer fall into this pat-
tern, as very little is known about safe margins of 
alcohol consumption (30).
Given the linear dose-response relation between 
alcohol intake and risk of cancer, control of heavy 
drinking remains the main target for cancer control 
(30). In healthy subjects, European Code against Can-
cer recommends keeping daily consumption within 
two drinks for men and one drink for women (30). 
There is insufficient data to support the actually safe 
intake of alcohol as any level of alcohol consumption 
dose-dependently associated with a reduced risk of 
alcohol on anticitrullinated protein antibody (ACPA) 
positive and ACPA-negative RA, but it was advised 
that a protective role of alcohol on RA risk must be 
interpreted with caution from a clinical and public 
health perspective (22).
Impact on the brain: Alcohol is associated with 
blurred vision, memory lapses, slurred speech, diffi-
culty walking and slow reaction time, all of which are 
due to the effect of alcohol on the brain (3). Chronic 
drinking increases the incidence of intracerebral 
haemorrhage (ICH), which can have severe conse-
quences. Chronic alcohol abuse also tends to elevate 
blood pressure, resulting in increased occurrence of 
hypertensive intracerebral haemorrhage (HICH) and 
exaggerated HICH-contributed brain injury (23). 
Alcohol consumption during pregnancy can produce 
a variety of central nervous system (CNS) abnormali-
ties in the child, resulting in a broad spectrum of cog-
nitive and behavioural impairments that constitute 
the most severe and long-lasting effects observed 
in foetal alcohol spectrum disorders (FASD) (24). 
The consequences of prenatal alcohol exposure on 
glial cells, including radial glia and other transient 
glial structures present in the developing brain, as-
trocytes, oligodendrocytes and their precursors and 
microglia contribute to abnormal neuronal develop-
ment, reduced neuron survival and disrupted brain 
architecture and connectivity (24). In addition, pre-
natal alcohol exposure affects iron homeostasis of 
specific brain areas (prefrontal cortex [PFC]) and the 
hippocampus, which could be involved in maladap-
tive cognition (25). Also, past and recent patterns 
of intermittent heavy alcohol consumption are as-
sociated with reduced frontal cortical thickness (i.e. 
“thinness”) of the right mid-anterior cingulate cor-
tex (ACC) and left posterior cingulate cortex (PCC) in 
emerging adults, but not the parieto-occipital sulcus 
(POS) (26). While cortical thinness can predate binge 
drinking, this pattern of maladaptive consumption 
may have acute neurotoxic effects that interfere 
with the finalization of neuromaturational processes 
in the vulnerable frontal cortex, resulting in increased 
microarchitectural pruning (26).
The findings from a study on the burden of binge and 
heavy drinking on the brain in adolescents and young 
adults suggest that altered neural structure and ac-
tivity in binge- and heavy-drinking youth may be re-
lated to the neurotoxic effects of consuming alcohol 
in large quantities during a highly plastic neurode-
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The volatility of alcohol promotes the movement 
of alcohol from the bronchial circulation across the 
airway epithelium and into the conducting airways 
of the lung; prolonged and heavy exposure to alco-
hol impairs mucociliary clearance, may complicate 
asthma management, and likely worsens outcomes 
including lung function and mortality in COPD pa-
tients (36). Although smoking is the primary cause of 
lung cancer, a slightly greater risk of lung cancer was 
associated with the consumption of less or = 30 g 
alcohol/d than with no alcohol consumption. Alcohol 
consumption is also strongly associated with greater 
risk in male never smokers (37). 
Chronic alcohol intake increased lung fibrosis in the 
bleomycin-model of lung injury, as this effect was re-
lated to increased production of transforming growth 
factor β (TGFβ) and expression of α-smooth muscle 
actin suggests that the lung is a target for alcohol, 
and that chronic alcohol intake may predispose the 
lung to disrepair after injury (38). The overexpres-
sion of pro-fibrotic growth factors and pro-inflamma-
tory cytokines, and the generation of oxidant stress 
may lead to lung cellular dysfunction, aberrant tissue 
remodelling and loss of lung function (38). 
In addition to the classic consequences of endotox-
emia associated with liver cirrhosis that were de-
scribed several decades ago, important research in 
the last ten years has shown that cytokines may also 
induce damage in remote organs such as brain, bone, 
muscle, heart, lung, gonads, peripheral nerve and 
pancreas, as these effects are even seen in alcohol-
ics without significant liver disease (39).
Crohn’s disease: A European prospective cohort 
study (EPIC) found that there was no evidence of 
associations between alcohol use and the odds of 
developing either ulcerative colitis (UC) or Crohn’s 
disease (CD) (40). Nevertheless, dietary guidelines 
for Crohn’s disease and ulcerative colitis include nu-
tritional deficiency screening, avoiding foods that 
worsen symptoms, eating smaller meals at more fre-
quent intervals, drinking adequate fluids, avoiding 
caffeine and alcohol, taking vitamin/mineral supple-
mentation, eliminating dairy if lactose intolerant, lim-
iting excess fat, reducing carbohydrates and reduc-
ing high-fibre foods during flares (41). 
Diabetes: Interestingly, light and moderate alcohol 
consumption was associated with a lower risk of 
type 2 diabetes (T2D), whereas heavy alcohol con-
sumption was not related to the risk of T2D, but cau-
increases the risk of developing alcohol-related can-
cer (30). 
The findings of a study on alcohol consumption and 
serum metabolite concentrations in young women 
revealed that alcohol was significantly associated 
with several serum metabolites such as the amino 
acid sarcosine, the omega-3 fatty acid eicosapentae-
noate, and the steroid 4- androsten-3beta, 17beta-
diol monosulfate were positively associated with 
alcohol intake (31). Furthermore, the findings of a 
study on light to moderate amount of lifetime alcohol 
consumption and risk of cancer in Japan revealed that 
light to moderate alcohol consumption appears to be 
associated with elevated cancer risks in Japan (32). 
Chronic obstructive pulmonary disease (COPD): 
Arvers has shown that there is a connection be-
tween COPD and alcohol consumption (33). Impor-
tantly, with a progressive desensitization of ciliary 
response, ethanol exposure reduces airway mucocili-
ary clearance; as a result, this important innate pri-
mary defence mechanism which protects the lungs 
from the deleterious effects of different pollutants, 
allergens and pathogens, is weakened (33). 
Chronic alcohol exposure alters the adaptative im-
mune response to pathogens (decreasing the phago-
cytic function of macrophages) and leads to an in-
flammatory response (pro-inflammatory cytokines) 
(33). Also, respiratory function is impaired by alcohol 
misuse: asthma, chronic obstructive pulmonary dis-
ease, lung infections, and the acute respiratory dis-
tress syndrome are more frequent and severe (33). In 
addition to neurodevelopmental effects, alcohol con-
sumption at high levels during pregnancy is associat-
ed with immunomodulation and premature birth (34). 
Premature birth, in turn, is associated with increased 
susceptibility to various infectious agents such as 
respiratory syncytial virus (RSV) (34). Hence, chronic 
maternal ethanol consumption during the third tri-
mester of pregnancy alters innate immune gene ex-
pression in foetal lung (34). These alterations may 
underlie increased susceptibility of preterm infants 
exposed to ethanol in utero, to RSV and other micro-
bial agents (34). Also, exposure to ethanol during the 
last trimester of pregnancy alters the maturation and 
immunity of the foetal lung (35). Hence, ethanol-me-
diated alterations in foetal lung maturation and im-
munity may explain the increased incidence of res-
piratory infections in neonates exposed to ethanol in 
utero (35). 
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consumption and epilepsy/unprovoked seizures (50). 
There was a dose-response relationship between the 
amount of alcohol consumed daily and the probabil-
ity of the onset of epilepsy as individuals consuming 
an average of four, six, and eight drinks daily had an 
overall relative risk compared to non-drinkers (50). 
Several pathogenic mechanisms for the development 
of epilepsy in alcohol users were identified. 
Most of the relevant studies found that a high per-
centage of alcohol users with epilepsy would qualify 
for the criteria of alcohol dependence (50). Impor-
tantly, two kinds of epileptic events are frequently 
related to alcohol consumption: 1) seizures triggered 
by alcohol withdrawal; often multiple, they occur 
within between 10 and 48 hours after discontinuing 
or reducing alcohol intake and can be followed by a 
delirium tremens; 2) recurring unprovoked seizures, 
which are usually rare, 1 or 2 yearly; the risk is in-
creased for heavy drinkers but returns to normal for 
ex-drinkers (51). Seizures related to alcoholism are 
usually generalized tonicoclonic seizures with normal 
electroencephalogram (EEG) and CT-scan (51). When 
partial seizures are identified, they are attributed to 
preceding brain damage, head trauma or stroke (51). 
Also, long-term alcohol intake increases the risk of 
epilepsy via activation of mammalian target of ra-
pamycin (mTOR) signalling (52). Moreover, ethanol-
induced mTOR activation may be dependent on the 
AKT-mTOR signalling pathway (52). The key mol-
ecules involved in AKT-mTOR signalling pathway 
may serve as potential targets in the treatment of 
epilepsy (52). In elderly patients, the most frequent 
causes of late-onset epilepsy seem to be cerebrovas-
cular disease, head trauma and alcoholism (53). The 
findings from an experimental approach study on 
alcohol consumption and sudden unexpected death 
in epilepsy revealed that there is a possible associa-
tion between alcohol abuse and sudden unexpected 
death in epilepsy (SUDEP) occurrence (54). Further-
more, the findings from a systematic review study 
of the risk factors associated with the onset and 
natural progression of epilepsy revealed that family 
history of epilepsy, history of febrile seizures, alco-
hol consumption, central nervous system (CNS) and 
other infections, brain trauma, head injury, perinatal 
stroke, preterm birth and three genetic markers are 
associated with the onset of epilepsy (55).
Heart disease and cardiovascular health: Heavy 
alcohol consumption can cause high blood pressure 
by triggering the release of certain hormones that 
tion must be taken as to what constitutes light and 
moderate drinking (42). In addition, excessive intake 
of alcohol may not only cause loss of metabolic con-
trol, but also annihilate the favourable effects on the 
cardiovascular system (43). 
According to a study on alcohol consumption, diabe-
tes risk and cardiovascular disease within diabetes, 
men consume more alcohol than women in popula-
tions with and without diabetes (44). Also, light-
to-moderate alcohol consumption decreases the 
incidence of diabetes in the majority of the studies, 
whereas heavy drinkers and binge drinkers are at in-
creased risk of developing diabetes (44). In addition, 
alcohol consumption may be a risk factor of diabetic 
lower extremity arterial disease (LEAD) in patients 
with T2D Mellitus (T2DM) (45). Hence, patients with 
T2DM are advised to stop drinking to prevent the on-
set of LEAD (45). 
A study on alcohol consumption and the risk of T2D 
revealed that relative to combined abstainers, re-
ductions in the risk of T2D were present at all lev-
els of alcohol intake <63 g/day, with risks increas-
ing above this threshold, as peak risk reduction was 
present between 10-14 g/day at an 18% decrease 
in hazards (46). Also, chronic alcohol consumption 
strongly increased the risk of T2D by increasing in-
sulin resistance (IR), especially in men with low T2D-
GRS, highlighting the importance of refraining from 
drinking alcohol when making recommendations for 
healthy lifestyle habits to prevent diabetes (47). Fur-
thermore, a study on occupational exposure to heavy 
metals, alcohol intake, and risk of T2D and prediabe-
tes among male Chinese workers revealed that expo-
sure to metal and heavy alcohol intake was associat-
ed with the risk of diabetes in a large cohort of male 
workers as there was a strong interaction between 
these two exposures in affecting diabetes risk. The 
risk of both T2D and prediabetes was significantly 
elevated with increasing number of standard drinks 
per week, years of drinking and lifetime alcohol con-
sumption (48). Importantly, during adolescence, fre-
quent alcohol consumption at levels reaching 5 or 
more drinks, 3-7 days/week, substantially increased 
the risk of diabetes in young adulthood; hence, heavy 
alcohol use during adolescence may increase the risk 
of diabetes in young adulthood (49). 
Epilepsy: The findings from a systematic review and 
meta-analysis study on alcohol consumption, unpro-
voked seizures and epilepsy revealed that there is a 
strong and consistent association between alcohol 
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considered for women, particularly for young women 
who may be susceptible to binge drinking (62). 
Among East Asians, even moderate alcohol consump-
tion can confer subclinical adverse effects on cardiac 
systolic functions, which was most pronounced in 
subjects carrying common variants in alcohol me-
tabolizing genes (63). These findings challenge the 
notion of beneficial influences of less heavy ethanol 
consumption on the heart, especially among East 
Asians (63). In a study on the impact of past and cur-
rent alcohol consumption patterns on progression of 
carotid intima-media thickness among women and 
men living with the human immunodeficiency virus 
(HIV) infection, the findings revealed that in both 
cohorts, 10-year heavy consumption was associ-
ated with statistically significant increases in carotid 
artery thickness, compared to abstinence (64). The 
long- term patterns of drinking at any level above 
abstinence were particularly significant for increases 
in intima-media thickness among men, with heavy 
consumption presenting with the greatest increase, 
and these findings suggest a potentially different 
window of risk among past and current heavy drink-
ers (64). 
Immune system dysfunction: Drinking too much 
alcohol weakens the immune system, thereby mak-
ing the body vulnerable to infectious diseases, such 
as pneumonia and tuberculosis, as alcohol causes 
changes in red blood cells, white blood cells and plate-
lets (3). Furthermore, heavy alcohol consumption in 
association with tobacco smoke and a deficient diet 
causes changes in the metabolism and distribution of 
carcinogens; alterations in cell cycle behaviour such 
as cell cycle duration leading to hyperproliferation; 
and nutritional deficiencies, such as methyl-, vitamin 
E-, folate-, pyridoxal phosphate-, zinc- and selenium 
deficiencies and alterations of the immune system, 
eventually resulting in an increased susceptibility to 
certain virus infections such as hepatitis B virus and 
hepatitis C virus (65). 
Moderate alcohol consumption is associated with re-
duced inflammation and improved responses to vac-
cination while chronic drinking is associated with a 
decreased frequency of lymphocytes and increased 
risk of both bacterial and viral infections (66). Fur-
thermore, acute alcohol inhibits, and chronic alcohol 
accelerates inflammatory responses (67). The pro-
inflammatory effects of chronic alcohol play a major 
role in the pathogenesis of alcoholic liver disease and 
pancreatitis, but also affect numerous other organs 
cause constriction of blood vessels which adversely 
affect the heart (3). Furthermore, alcohol consump-
tion has a major and complex impact on cardiovas-
cular diseases, as both irregular and chronic heavy 
drinking occasions detrimentally impact most major 
cardiovascular disease categories, whereas light to 
moderate drinking has been associated with benefi-
cial effects on ischemic heart disease and ischemic 
stroke (56). 
Heavy drinking (more than 4 drinks per day) is as-
sociated with an increased risk of death and cardio-
vascular (CV) diseases (CVD) (57). Excessive alcohol 
intake trails behind only smoking and obesity among 
the three leading causes of premature deaths in the 
USA, as heavy alcohol use is a common cause of re-
versible hypertension, non-ischaemic dilated car-
diomyopathy, atrial fibrillation (AF) and stroke (both 
ischemic and haemorrhagic) (57). Furthermore, the 
increased risks of heavy drinking, defined as three or 
more standard-sized drinks per day, are both cardio-
vascular (CV) and non-CV (58). CV risks include the 
following: (i) alcoholic cardiomyopathy (ACM), (ii) sys-
temic hypertension, (iii) atrial arrhythmias, (iv) haem-
orrhagic stroke and probably ischaemic stroke (58). 
In addition, alcohol consumption decreases myocar-
dial contractility and induces arrhythmias and dilated 
cardiomyopathy, resulting in progressive cardiovascu-
lar dysfunction and structural damage (59). Alcohol, 
whether at binge doses or a high cumulative lifetime 
consumption, both of which should be discouraged, 
is clearly deleterious for the cardiovascular system, 
increasing the incidence of total and cardiovascular 
mortality, coronary and peripheral artery disease, 
heart failure, stroke, hypertension, dyslipidaemia and 
diabetes mellitus (59). A study on heavy alcohol con-
sumption and its association with impaired endothe-
lial function revealed that heavy alcohol consump-
tion may be an independent risk factor of endothelial 
dysfunction in Japanese men (60). The findings from 
a cohort study on the association between alcohol 
consumption and risk of myocardial infarction (MI) 
and heart failure (HF) revealed that alcohol consump-
tion has divergent associations with MI and HF, with 
an inverse association observed for MI but not HF 
(61). Furthermore, heavy drinking was associated 
with an increased HF risk in men (61). Importantly, 
women with moderate to heavy alcohol intake had 
a significantly increased risk of morbidity and total 
mortality compared with men in multiple subpopula-
tions (62). Hence, control of alcohol intake should be 
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permeability to luminal bacterial products and the 
subsequent development of alcoholic liver disease 
(ALD), as well as other diseases (72). In addition, clin-
ical and preclinical data suggest that alcohol-related 
disorders are associated with quantitative and quali-
tative dysbiotic changes in the intestinal microbiota 
and may be associated with increased GIT inflamma-
tion, intestinal hyperpermeability, resulting in endo-
toxemia, systemic inflammation and tissue damage/
organ pathologies including ALD (72). 
Furthermore, chronic alcohol consumption promotes 
diethylnitrosamine-induced hepatocarcinogenesis 
via immune disturbances as chronic alcohol consump-
tion exacerbates DEN-induced hepatocarcinogenesis 
by enhancing protumor immunity, impairing antitu-
mor immunity and aggravating hepatic pathological 
injury (73). 
In assessing the role of alcohol during hepatic dis-
ease, and as a carcinogen, many of the deleterious 
effects of alcohol can be attributed to alcohol metab-
olism in hepatocytes (74). In addition to the direct 
effects of alcohol/alcohol metabolism on hepatocyte 
transformation, increasing evidence indicates that 
other intrahepatic and systemic effects of alcohol are 
likely to play an equally significant role in the process 
of hepatic tumorigenesis (74). 
Malnourishment and vitamin deficiencies: Dys-
functional drinking leads to malnourishment and 
vitamin deficiencies (75). Furthermore, chronic alco-
holic patients are frequently deficient in one or more 
vitamins, and the deficiencies commonly involve 
folate, vitamin B6, thiamine and vitamin A (76). Al-
though inadequate dietary intake is a major cause of 
vitamin deficiency, other possible mechanisms may 
also be involved as alcoholism can affect the absorp-
tion, storage, metabolism and activation of many vi-
tamins (76). 
Malabsorption occurs frequently in chronic alcohol-
ics, as alcoholics may malabsorb fat, nitrogen, sodium, 
water, thiamine, folic acid, vitamin B12 and D-xylose 
(77). Malabsorption occurs due to an abnormal luminal 
phase of digestion as well as a diffuse functional mu-
cosal abnormality (77). Malabsorption may, therefore, 
contribute to clinically significant malnutrition, diar-
rhoea, folate-deficiency and abnormalities in tests of 
xylose and vitamin B12 absorption (77). Factors pro-
ducing malabsorption in alcoholics include dietary folic 
acid and protein deficiency, pancreatic insufficiency, 
abnormalities of biliary secretions and direct effects of 
and tissues (67). In addition to promoting proinflam-
matory immune responses, alcohol also impairs anti-
inflammatory cytokines (67). 
Likewise, chronic alcohol exposure also interferes 
with the normal functioning of all aspects of the 
adaptive immune response, including both cell-medi-
ated and humoral responses (67). The findings from a 
study on prenatal alcohol exposure and the develop-
ing immune system revealed that alcohol may have 
indirect effects on the immune system by increasing 
the risk of premature birth, which itself is a risk fac-
tor for immune-related problems (68). Animal studies 
suggest that alcohol exposure directly disrupts the 
development of the immune system (68). 
Chronic alcohol abuse reduces the number of periph-
eral T cells, disrupts the balance between different 
T-cell types, influences T-cell activation, impairs T-
cell functioning and promotes T-cell apoptosis (69). 
Likewise, chronic alcohol consumption also seems 
to cause the loss of peripheral B cells, while simul-
taneously inducing increased production of immu-
noglobulins (69). The levels of antibodies against 
liver-specific auto antigens are increased in patients 
with alcoholic liver disease and may promote alcohol-
related liver damage (69). 
Finally, chronic alcohol exposure in utero interferes 
with normal T-cell and B-cell development, which 
may increase the risk of infections during both child-
hood and adulthood (69). The impact of alcohol on T 
cells and B cells increases the risk of infections (e.g. 
pneumonia, HIV infection, hepatitis C virus infection 
and tuberculosis), impairs responses to vaccinations 
against such infections, exacerbates cancer risk and 
interferes with delayed-type hypersensitivity (69).
Liver diseases: Liver is the main organ responsible 
for metabolizing ethanol, and therefore the major 
victim of alcohol abuse (3). Ethanol and its bioactive 
products, acetaldehyde-acetate, fatty acid ethanol 
esters and ethanol-protein adducts, have been re-
garded as hepatotoxins that directly and indirectly 
exert their toxic effect on the liver (70). Importantly, 
alcoholic liver disease (ALD) is a leading cause of cir-
rhosis, liver cancer, and acute and chronic liver fail-
ure, and as such causes significant morbidity and 
mortality (71). 
Alcohol-induced changes in the gastrointestinal tract 
(GIT) microbiota composition and metabolic function 
may contribute to the well-established link between 
alcohol-induced oxidative stress, intestinal hyper-
236 Israel O Ayenigbara. Chronic Alcohol Use and Accompanying Noncommunicable Diseases. Croat Nurs J. 2020; 4(2): 227-242
risk of depression (82). Importantly, alcohol abuse, 
but not dependence, precedes many mood and anxi-
ety disorders, and if the primary disorder does in fact 
play a causative or contributing role in the develop-
ment of the subsequent disorder, this role can best 
be described as “temporally distal” (83). 
The findings from a comparative study on the bur-
den of cyclothymia on alcohol dependence revealed 
that CT traits in alcohol dependents seems to influ-
ence whether subjects engage earlier in pathologi-
cal alcohol use and present particular alcohol-related 
problems, in particular Cloninger type II alcoholism 
phenotype (84).
Osteoporosis and bone malformation: Chronic al-
cohol consumption, particularly during adolescence 
and young adulthood, can dramatically affect bone 
health, and it may increase the risk of developing 
osteoporosis, with a loss of bone mass, later in life 
(85). Likewise, alcohol consumption is a risk factor for 
osteoporosis based on frequent findings of low bone 
mass, decreased bone formation rate and increased 
fracture incidence in alcoholics (85). 
Alcohol has been shown to reduce bone formation 
in healthy humans and animals and to decrease pro-
liferation of cultured osteoblastic cells (85). Second-
ary causes of osteoporosis include hypercortisolism, 
hyperthyroidism, hyperparathyroidism, alcohol abuse 
and immobilization (86). Importantly, heavy alcohol 
consumption is generally associated with decreased 
bone mineral density (BMD), impaired bone quality and 
increased fracture risk (87). Bone remodelling is the 
principal mechanism for maintaining a healthy skel-
eton in adults, and dysfunction in bone remodelling 
can lead to bone loss and/or decreased bone quality 
(87). Decrease in bone mass and strength following 
alcohol consumption is mainly due to bone remodel-
ling imbalance, with a predominant decrease in bone 
formation (88). However, recent studies have shown 
new mechanisms by which alcohol may act on bone 
remodelling, including osteocyte apoptosis, oxidative 
stress, and Wnt signalling pathway modulation (88). 
The findings from a study on the effect of chronic 
alcohol consumption on the longitudinal growth of 
the tibia and bone quality parameters in young rats 
under an experimental setup revealed that chronic 
consumption of alcohol affected the bones of young 
rats, making them weaker and osteopenic (89). In ad-
dition, long bones were shorter, suggesting interfer-
ence with growth (89). 
alcohol on the gastrointestinal tract, but many of the 
absorptive abnormalities are reversed when alcoholics 
are given a nutritious diet (77). 
Also, chronic alcohol consumption leads to deficiency 
of this vitamin due to dietary inadequacy, intesti-
nal malabsorption, decreased hepatic uptake and 
increased body excretion, mainly via urine, and de-
creased concentration of serum folic acid may occur in 
80.5% of alcoholics (78). The cause of elevated con-
centrations of homocysteine in the serum of alcohol 
abusers is a deficiency of vitamins involved, such as 
vitamin B12 and pyridoxal phosphate, as disturbance 
of folic acid and homocysteine metabolism in alco-
hol abusers can lead to serious clinical consequences 
such as macrocytic and megaloblastic anaemia and 
neurological disorders, as megaloblastic anaemia 
occurs in about half of alcohol abusers with chronic 
liver diseases (78). In turn, a high level of homocyst-
eine in blood is associated with an increased risk of 
cardiovascular diseases, ashyperhomocysteinemia 
is an independent risk factor that favours the occur-
rence of acute coronary syndromes in patients with 
coronary heart disease (78). 
The findings from a study on nutritional deficiencies 
in chronic alcoholics revealed that over-malnutrition 
is infrequent in this group of chronic alcoholics; spe-
cific vitamin deficiencies are present in a substantial 
proportion of patients and are more likely related to 
alcohol consumption (79). Importantly, among healthy, 
well-nourished, postmenopausal women, moderate al-
cohol intake may diminish vitamin B12 status (75). 
Mood disorders (bipolar disorder, cyclothymic 
disorder and depression): Mood disorders and al-
cohol use are common in the general population and 
often occur together (80). Mood disorders, particular-
ly bipolar disorder, act as unique risk factors for first 
alcohol use in the general population and show sig-
nificant interactions with developmental timing (80). 
The findings from a study on anxiety disorders and 
first alcohol use in the general population revealed 
that early onset anxiety disorders significantly pre-
dict first alcohol use in the general population, and 
this relationship appears to be related to change over 
time, which points to the need for developmentally 
appropriate and integrated prevention programs that 
target anxiety and alcohol use together (81). 
There is also a causal linkage between alcohol use 
disorders and major depression, such that increasing 
involvement with alcohol consumption increases the 
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alcohol interferes with gastric acid secretion and with 
the activity of the muscles surrounding the stomach 
(95). Similarly, alcohol may impair muscle movement 
in the small and large intestines, contributing to diar-
rhoea frequently observed in alcoholics (95). Moreo-
ver, alcohol inhibits the absorption of nutrients in the 
small intestine and increases the transport of toxins 
across the intestinal walls, effects that may contrib-
ute to the development of alcohol-related damage to 
the liver and other organs (95). 
In addition, excessive alcohol consumption (even 
a single episode) can result in duodenal erosions 
and bleeding, and mucosal injury in the upper je-
junum (96). An increased prevalence for bacterial 
overgrowth in the small intestine may contribute to 
functional and/or morphological abnormalities of this 
part of the gut and also to non-specific abdominal 
complaints in alcoholics (96). The mucosal damage 
caused by alcohol increases the permeability of the 
gut to macromolecules and this facilitates the trans-
location of endotoxin and other bacterial toxins from 
the gut lumen to the portal blood, thereby increasing 
the liver’s exposure to these toxins and, consequent-
ly, the risk of liver injury (96). 
Examples of more pronounced organ injury which 
can occur even following a single episode of heavy 
drinking are tears in the mucosa at the junction of 
the oesophagus and the stomach (Mallory-Weiss le-
sion) and haemorrhagic erosions in the stomach and/
or the duodenum which may lead to massive bleed-
ing (97). In the small intestine, alcohol abuse inter-
feres with the absorption of glucose, amino acids, 
lipids, water, sodium and vitamins (especially thia-
mine and folic acid), as this inhibition of absorption of 
nutrients may contribute to nutritional deficiencies 
frequently observed in alcoholics (97).
Acute alcohol ingestion can also damage the mucosa 
in the upper region of the small intestine and may 
lead to the disruption of the tips of the villi (97). Vari-
ous diseases of the GIT, including tumours, may be 
related to excessive alcohol intake and the relation-
ship between alcohol abuse and hepatic and pancre-
atic damage is well established (98). Importantly, 
alcohol-induced changes in the GIT microbiota com-
position and metabolic function may contribute to 
the well-established link between alcohol-induced 
oxidative stress, intestinal hyperpermeability to lu-
minal bacterial products and the subsequent devel-
opment of alcoholic liver disease (ALD), as well as 
other diseases (72). 
The findings from a study on voluntary chronic 
heavy alcohol consumption in male rhesus macaques 
revealed that voluntary chronic heavy alcohol con-
sumption reduces cancellous bone formation in lum-
bar vertebra by decreasing osteoblast-lined bone 
perimeter, a response associated with an increase in 
bone marrow adiposity (90).
Pancreatitis: Overconsumption of alcohol can lead 
to pancreatitis, a painful inflammation of the pan-
creas that often requires hospitalization (91). Chronic 
abuse of alcohol, but not occasional alcoholic intoxi-
cation, also causes pancreatic damage (92). 
Alcohol is metabolized by the pancreas via both oxi-
dative and non-oxidative metabolites; hence, alcohol 
and its metabolites produce changes in the acinar 
cells, which may promote premature intracellular di-
gestive enzyme activation, thereby predisposing the 
gland to autodigestive injury (93). Pancreatic stel-
late cells (PSCs) are activated directly by alcohol and 
its metabolites and also by cytokines and growth 
factors released during alcohol-induced pancreatic 
necroinflammation (93). Activated PSCs are the key 
cells responsible for producing the fibrosis of alco-
holic chronic pancreatitis (93). 
The findings from a study on the impact of alcohol 
consumption on pancreatic diseases revealed that 
high alcohol intake was associated with a higher risk 
of pancreatitis (around 2.5%-3% among heavy drink-
ers and 1.3% among non-drinkers) (94). Furthermore, 
about 70.5% of pancreatitis cases are due to chronic 
heavy alcohol consumption, and although this inci-
dence rate differs between countries, it is clear that 
the risk of developing pancreatitis increases with in-
creasing doses of alcohol and the average of alcohol 
consumption (94).
Ulcers and gastrointestinal problems: Heavy 
drinking can cause problems with the digestive sys-
tem, such as acid reflux, heartburn and inflammation 
of the stomach lining, known as gastritis (3). When 
alcohol is consumed, the alcoholic beverage first 
passes through the various segments of the gas-
trointestinal (GI) tract (95). Accordingly, alcohol may 
interfere with the structure as well as the function 
of GI-tract segments. For instance, alcohol can impair 
the function of the muscles separating the oesopha-
gus from the stomach, thereby favouring the occur-
rence of heartburn (95). Alcohol-induced damage to 
the mucosal lining of the oesophagus also increases 
the risk of oesophageal cancer (95). In the stomach, 
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imunološkog sustava, pothranjenost i nedostatak vi-
tamina, poremećaje raspoloženja, bipolarni poreme-
ćaj i depresiju, osteoporozu i deformaciju kosti, upalu 
gušterače te čireve i gastrointestinalne probleme.
Zaključak. Ovi uvidi predstavljaju pozadinski sadržaj 
jer upućuju na određene nezarazne bolesti povezane 
s kroničnom konzumacijom alkohola, stoga je potreb-
no više preciznih dugoročnih kohortnih istraživanja 
kako bi se bolje razumjelo pojave i epidemiologiju 
nezaraznih bolesti koje su posljedica kronične konzu-
macije alkohola.
Ključne riječi: obrazac, kronično, konzumacija alkohola, 
nezarazne bolesti
Sažetak
Uvod. Prekomjeran i kroničan unos alkohola pred-
stavlja učestalo, kontinuirano i ustrajno konzumiranje 
alkoholnih pića tijekom dužeg razdoblja. Prekomjerna 
konzumacija alkohola uzrokuje brojne zdravstvene 
probleme pojedincu, ali i cijelome društvu, te se više 
od 5,1  % globalnog moraliteta i bolesti pripisuje 
isključivo konzumaciji alkohola.
Cilj. Svrha je ovog istraživanja sustavnim pregledom 
literature i detaljnim opisom pojava prepoznati neza-
razne bolesti koje se vežu uz kroničnu konzumaciju 
alkohola.
Metode. Sustavni pregled literature kojim se utvrdilo 
koje su nezarazne bolesti povezane s konzumacijom 
alkohola proveden je upotrebom Googlea, Medlinea 
i baza podataka velikih međunarodnih zdravstvenih 
organizacija. Ključne riječi upotrijebljene pri pretraži-
vanju bile su alkoholizam i kronična konzumacija al-
kohola. Te se pojmove povezalo s pojavama i rizikom 
od nezaraznih bolesti. Istraživanja uključena u ovaj 
pregled obuhvaćaju klinička ispitivanja, metaanalize, 
kontrolirana klinička ispitivanja sa slučajnim uzorkom 
te pregledne članke.
Rezultati. Istraživanje je pokazalo da kronična kon-
zumacija alkohola predstavlja jedan od čimbenika ri-
zika za Alzheimerovu bolest i demenciju, artritis, ne-
pravilnu moždanu funkciju, rak (najčešće rak ždrijela, 
jednjaka, jetre, debelog crijeva, rektuma i dojke), kro-
ničnu opstruktivnu bolest pluća, dijabetes, epilepsi-
ju, bolesti srca i kardiovaskularne bolesti, disfunkciju 
KRONIČNA UPOTREBA ALKOHOLA I POPRATNE NEZARAZNE BOLESTI
